Κλαύδιος Γαληνός
Δωρεάν εγγραφή Αποκτήσετε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr για έναν μήνα
Γαληνός Office Χρησιμοποιήστε δωρεάν το νέο cloud πρόγραμμα διαχείρισης κάθε σύγχρονου ιατρείου
Έλεγχος συγχορήγησης Ελέγξτε την αγωγή σας για αντενδείξεις και αλληλεπιδράσεις μεταξύ των φαρμάκων
Μητρότητα και φάρμακα Ενημερωθείτε για την ασφάλεια χορήγησης ενός φαρμάκου κατά τη διάρκεια της εγκυμοσύνης ή του θηλασμού
Πρόγραμμα συνδρομητών Μάθετε περισσότερα για τα οφέλη και τις επιπλέον παροχές των συνδρομητικών προγραμμάτων
Γαληνός Mobile Κατεβάστε τη δωρεάν εφαρμογή και απολαύστε τις υπηρεσίες του Galinos.gr σε κινητό ή tablet
Γνωρίζατε οτι... Μοιραζόμαστε μαζί σας γεγονότα της πορείας του Galinos.gr από το 2011 μέχρι σήμερα
®
 Περιεχόμενα  Φάρμακα Α - Ζ  Συγχορήγηση

PROSTIN E2 Concentrate for solution for infusion (2018)

Αναφορές

Βιβλιογραφική αναφορά

Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

Περιεχόμενα

Name of the medicinal product

Prostin E2 Sterile Solution 1 mg/ml.

Qualitative and quantitative composition

Each ml contains 1 mg dinoprostone (750 micrograms per ampoule). Following dilution in accordance with instructions, each ml of the resultant solution for infusion contains 1.5 micrograms dinoprostone. ...

Pharmaceutical form

Concentrate for solution for infusion (sterile concentrate). The concentrate is a clear, colourless, alcoholic solution free from particulate matter, which after appropriate dilution is intended for intravenous ...

Therapeutic indications

Oxytocic agent. Prostin E2 Sterile Solution 1 mg/ml is indicated for the induction of labour by the intravenous route.

Posology and method of administration

Posology Adults Directions for the Preparation of a Dilute Solution: For use by IV drip (a drip set delivering 60 drops/per ml must be used) or constant rate infusion pump. Withdraw 0.75 ml from the ampoule ...

Contraindications

Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1. Prostin E2 Sterile Solution should not be used where the patient is sensitive to prostaglandins. Prostin E2 ...

Special warnings and precautions for use

This product is only available to hospitals and clinics with specialised obstetric units and should only be used where 24-hour resident medical cover is provided. Use caution in handling this product to ...

Interaction with other medicinal products and other forms of interaction

Since it has been found that prostaglandins potentiate the effect of oxytocin, it is not recommended that these drugs are used together. If used in sequence, the patients uterine activity should be carefully ...

Pregnancy and lactation

Pregnancy Prostin E2 Sterile Solution 1 mg/ml is only used during pregnancy, to induce labour. Breast-feeding Prostaglandins are excreted in breast milk. This is not expected to be a hazard given the circumstances ...

Effects on ability to drive and use machines

The amount of alcohol (ethanol) in this medicinal product may impair the patients ability to drive or use machines.

Undesirable effects

Cardiac disorders: Cardiac arrest Vascular disorders: Hypertension Gastrointestinal disorders: Diarrhoea, nausea, vomiting General disorders and administration site conditions: Fever, local tissue irritation/erythema ...

Overdose

Over dosage may be expressed by uterine hypercontractility and uterine hypertonus. During use, uterine activity, fetal status and the progression of cervical dilation should be carefully monitored to detect ...

Pharmacodynamic properties

Pharmacotherapeutic group: Prostaglandins ATC-code: G02AD02 Dinoprostone is a prostaglandin of the E series with actions on smooth muscle. It induces contraction of uterine muscle at any stage of pregnancy. ...

Pharmacokinetic properties

Dinoprostone is rapidly metabolised in the body. Intravenous administration results in very rapid distribution and metabolism, with only 3% of unchanged drug remaining in the blood after 15 minutes. At ...

Preclinical safety data

There are no preclinical data of relevance which are additional to that already included in other sections of the Summary of Product Characteristics.

List of excipients

Dehydrated alcohol (ethanol)

Incompatibilities

Not applicable.

Shelf life

2 years.

Special precautions for storage

Store in a refrigerator at 2-8°C. Once diluted, the diluted solution should be stored in a refrigerator at 2-8°C and used within 24 hours.

Nature and contents of container

Ph. Eur. Type I glass ampoule, containing 0.75 ml sterile solution, packed in a carton.

Special precautions for disposal and other handling

Use caution in handling this product to prevent contact with skin. Wash hands thoroughly with soap and water after administration. Any unused medicinal product or waste material should be disposed of in ...

Marketing authorization holder

Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK

Marketing authorization number(s)

PL 00057/1028

Date of first authorization / renewal of the authorization

Date of first authorisation: 27 June 1986 Date of latest renewal: 28 October 2004

Date of revision of the text

01/2018

Πηγαίο έγγραφο

Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση: